Loading…
Based on limited metadata, the FDA issued a warning letter to Capris Associates Inc. / BR Naturals on February 5, 2019, regarding dietary supplements. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The warning falls under FDA's regulatory oversight of dietary supplement products, though the specific issuing office is not identified in the metadata provided.